Targeting glutamate signalling in depression: progress and prospects.
about
HCN Channel Targets for Novel Antidepressant Treatment.Contribution of Vesicular Glutamate Transporters to Stress Response and Related Psychopathologies: Studies in VGluT3 Knockout Mice.Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.Engaging homeostatic plasticity to treat depression.The rapid-onset antidepressant effect of ketamine: More surprises?Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.Alternatives to ketamine in depression: state-of-the-art and future perspectives.Functional Magnetic Resonance Spectroscopy: The "New" MRS for Cognitive Neuroscience and Psychiatry Research.Impaired social behaviors and minimized oxytocin signaling of the adult mice deficient in the N-methyl-d-aspartate receptor GluN3A subunit.Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways.Ketamine and ketamine metabolites as novel estrogen receptor ligands: Induction of cytochrome P450 and AMPA glutamate receptor gene expression.Convergent Mechanisms Underlying Rapid Antidepressant Action.Elevated peripheral blood glutamate levels in major depressive disorder.Ketamine differentially restores diverse alterations of neuroligins in brain regions in a rat model of neuropathic pain-induced depression.Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonist.Medium- and high-intensity rTMS reduces psychomotor agitation with distinct neurobiologic mechanisms.Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic ReviewKetamine, but Not the NMDAR Antagonist Lanicemine, Increases Prefrontal Global Connectivity in Depressed PatientsThe effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjectsPrefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine TreatmentChronic Pain and Chronic Stress: Two Sides of the Same Coin?Parkinson's disease-linked Parkin mutations impair glutamatergic signaling in hippocampal neurons
P2860
Q34557298-1A7E17F7-99DB-4F6A-A053-3210182B1D65Q38641772-C31362E8-737D-42CE-A4FE-163D5DF83894Q47383203-AAD82E39-116E-4CFD-9431-E4A4730C7BB2Q47406465-508CE8C2-97AA-4EE4-A126-9B2A3796EAD1Q47409882-6198ED8C-743E-4977-A5B5-A0BE5A36B972Q47688167-D20430FF-91D5-472C-AF8F-158F0B9178E4Q50355682-8FFC17EA-6AE1-4B1C-8A0F-CAEE7DB212DFQ51758661-DD760F63-BA0B-4409-B39D-F13FA1C7B1BAQ52350440-50EBAB3D-5270-4060-867D-012D86FAEC91Q52584632-0491E651-DDCD-47C1-8D6D-610ABA9ABCA9Q52604451-BD60C79D-5598-4957-B0F3-E3145559783FQ52667723-0744F7F8-3E93-4C60-ABBC-763EE0835DB2Q55248119-9AB871B6-AE03-4A67-A670-1E72DD3E56A5Q55266208-B0671665-EA19-4A0A-9DFC-693C0E8FDC7AQ55368711-589002E8-CEF9-4B47-9179-9E6F2A6A9972Q55483713-AEC4E3FA-8DA1-47D2-A546-2E8D8B3DAB4FQ57174889-1241E434-8BCA-464E-B240-2A1318A1415EQ58213311-44FF2FA8-E181-4891-82D4-B4C68E9D9FDFQ58213859-EF881446-7F50-424B-A539-D9EC5569ADA5Q58213868-0CEFA0BB-F222-410C-97D2-5D974DF435AAQ58213881-529A824F-93BE-4FAC-9BC4-7D801CD72421Q58756675-C8FE0B9D-4D2E-46E2-A5C2-3F91EF551EF6
P2860
Targeting glutamate signalling in depression: progress and prospects.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Targeting glutamate signalling in depression: progress and prospects.
@en
type
label
Targeting glutamate signalling in depression: progress and prospects.
@en
prefLabel
Targeting glutamate signalling in depression: progress and prospects.
@en
P2860
P356
P1476
Targeting glutamate signalling in depression: progress and prospects.
@en
P2093
James W Murrough
Sanjay J Mathew
P2860
P2888
P304
P356
10.1038/NRD.2017.16
P577
2017-03-17T00:00:00Z